|
Volumn 72, Issue 2, 2005, Pages 105-110
|
The use of triphasic oral contraceptives in a continuous use regimen
|
Author keywords
Continuous use; Hormone withdrawal symptoms; Menstrual cycle control; Triphasic oral contraceptives
|
Indexed keywords
CYCLESSA;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS NORETHISTERONE;
ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;
ETHINYLESTRADIOL PLUS NORGESTIMATE;
ORAL CONTRACEPTIVE AGENT;
ORTHO TRI CYCLEN LO;
TRIPHASIC CONTRACEPTIVE AGENT;
UNCLASSIFIED DRUG;
ADULT;
ANAMNESIS;
ARTICLE;
BREAKTHROUGH BLEEDING;
BREAST TENDERNESS;
CLINICAL ARTICLE;
COMMUNITY;
DATA ANALYSIS;
DEMOGRAPHY;
DRUG USE;
DRUG WITHDRAWAL;
FEMALE;
HEADACHE;
HUMAN;
INCIDENCE;
MEDICAL PRACTICE;
MEDICAL RECORD;
MENTAL INSTABILITY;
NAUSEA;
PARITY;
PATIENT;
PHYSICIAN;
PREGNANCY;
RETROSPECTIVE STUDY;
SIDE EFFECT;
SPOTTING;
SURVIVAL;
TREATMENT OUTCOME;
WEIGHT GAIN;
WITHDRAWAL BLEEDING;
ADOLESCENT;
ADULT;
BODY MASS INDEX;
CONTRACEPTION;
CONTRACEPTIVES, ORAL, COMBINED;
CONTRACEPTIVES, ORAL, SEQUENTIAL;
CONTRACEPTIVES, ORAL, SYNTHETIC;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MENSTRUAL CYCLE;
MIDDLE AGED;
PATIENT ACCEPTANCE OF HEALTH CARE;
RETROSPECTIVE STUDIES;
SMOKING;
SUBSTANCE WITHDRAWAL SYNDROME;
|
EID: 22044445942
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/j.contraception.2005.02.015 Document Type: Article |
Times cited : (8)
|
References (9)
|